1[1]Bohan A, Peter JB. Polymyositis and dermatomyositis. N Engl Med,1975,292:344,403.
2[2]Dalakas MC. Muscle biopsy findings in inflammatory myopathies.Rheum Dis CLin N Am,2002,28:779 ～798.
3[3]Alison M, Emslie-Smith MB, Andrew G, et al. Microvascular changes in early and advanced dermatomyositis: a quantitative study. Annals of Neurology, 1990,27: 343 ～ 356.
4[4]Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis. Lancet,2003,362:971 ～ 982.
5[5]Estruch R, Grau J, Fernandez-sola J, et al. Microvascular changes in skeletal muscle in idiopathic inflammatory myopathy. Human Pathology, 1992,23:888 ～ 895.
6[6]Dawson JM, Tyler KR, Hudlicka O. A comparison of the microcirculation in rat fast glycolytic and slow oxidative muscles at rest and during contractions. Microvasc Res, 1987,33:167 ～ 182.
7[7]William E ,Kevin E ,Joseph E, et al. Clinical and pathogenetic implications of histopathology in childhood polydermatomyositis. Arthritis and Rheumatism, 1982,25:126 ～ 139.
8[8]Matsubara S, Hirai S, Saws Y. Pulsed intravenous methylprednisolone therapy for inflammatory myopathies:evaluation of the effect by comparing two consecutive biopsies from the same muscle. J Neuroimmunol, 1997,76:75 ～ 80.
9[9]Carpenter S, Karpati G. Pathology of skeletal muscle. New York, NY:Churchill Livingstone Inc. 1984:581 ～ 587.
10[10]Kissel JT, Halterman RK, Rammohan KW, et al. The relationship of complement-mediated microvasculopathy to the histologic features and clinical duration of disease in dermatomyositis. Arch Neurol, 1991,48:26 ～ 30.
